ArticleCancer medicine2021

Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.

Hee Sun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.